Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes

[1]  Lisle E. Mose,et al.  Prognostic value of B cells in cutaneous melanoma , 2019, Genome Medicine.

[2]  Ying Cheng,et al.  Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients , 2019, Nature Communications.

[3]  Xianjun Yu,et al.  KrasG12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancer. , 2019, Cancer letters.

[4]  J. Gartner,et al.  Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients , 2019, Nature Communications.

[5]  U. Harmenberg,et al.  A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis , 2018, British Journal of Cancer.

[6]  M. Maeurer,et al.  KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer , 2018, Front. Oncol..

[7]  B. Nelson,et al.  Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer , 2018, Clinical Cancer Research.

[8]  L. Villa,et al.  B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses , 2018, PloS one.

[9]  P. Laurent-Puig,et al.  TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma , 2018, Clinical Cancer Research.

[10]  Steven J. M. Jones,et al.  The Immune Landscape of Cancer , 2018, Immunity.

[11]  A. Gallimore,et al.  Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease? , 2017, Front. Immunol..

[12]  Rohit Loomba,et al.  Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity , 2017, Nature.

[13]  G. Cavet,et al.  Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens. , 2017, Clinical immunology.

[14]  M. McCarter,et al.  Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non–Small Cell Lung Cancer Patients , 2017, Cancer Immunology Research.

[15]  Jin-liang Kong,et al.  Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis , 2017, PloS one.

[16]  M. Menon,et al.  Human regulatory B cells in health and disease: therapeutic potential , 2017, The Journal of clinical investigation.

[17]  C. Chapman,et al.  Autoantibodies: Opportunities for Early Cancer Detection. , 2017, Trends in cancer.

[18]  J. Gartner,et al.  T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. , 2016, The New England journal of medicine.

[19]  C. Perou,et al.  Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types. , 2016, Journal of the National Cancer Institute.

[20]  H. Asamura,et al.  Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  H. Pass,et al.  Autoantibodies against tumor-associated antigens in the early detection of lung cancer. , 2016, Lung cancer.

[22]  Joel S. Parker,et al.  Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJer , 2016, Bioinform..

[23]  Evgeny S. Egorov,et al.  High-quality full-length immunoglobulin profiling with unique molecular barcoding , 2016, Nature Protocols.

[24]  K. Jirström,et al.  Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer. , 2016, Heliyon.

[25]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[26]  Mikhail Pogorelyy,et al.  VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires , 2015, PLoS Comput. Biol..

[27]  Steven Eschrich,et al.  Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma , 2015, Oncogene.

[28]  Ash A. Alizadeh,et al.  Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .

[29]  P. Marrack,et al.  CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCs , 2015, The Journal of Immunology.

[30]  P. Validire,et al.  A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4+ T cell receptor repertoire clonality , 2015, Oncoimmunology.

[31]  Mikhail Shugay,et al.  MiXCR: software for comprehensive adaptive immunity profiling , 2015, Nature Methods.

[32]  Edgar G. Engleman,et al.  Allogeneic IgG combined with dendritic cell stimuli induces anti-tumor T cell immunity , 2015, Nature.

[33]  A. Gómez,et al.  A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer , 2015, Clinical and Translational Oncology.

[34]  Christopher J. Kane,et al.  Immunosuppressive plasma cells impede T cell-dependent immunogenic chemotherapy , 2015, Nature.

[35]  S. Gnjatic,et al.  Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity , 2015, Front. Immunol..

[36]  F. Marincola,et al.  Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer , 2014, Journal of Translational Medicine.

[37]  M. Kris,et al.  Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation. , 2014, Clinical lung cancer.

[38]  R. Emerson,et al.  PD-1 blockade induces responses by inhibiting adaptive immune resistance , 2014, Nature.

[39]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[40]  Simon A. Jones,et al.  Ectopic lymphoid-like structures in infection, cancer and autoimmunity , 2014, Nature Reviews Immunology.

[41]  V. D. Dang,et al.  From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets. , 2014, Current opinion in immunology.

[42]  P. Validire,et al.  Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. , 2014, American journal of respiratory and critical care medicine.

[43]  S. Qiu,et al.  Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma , 2013, Clinical Cancer Research.

[44]  D. McMillan,et al.  The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer , 2013, British Journal of Cancer.

[45]  A. Yoshizawa,et al.  Stromal plasma cells expressing immunoglobulin G4 subclass in non-small cell lung cancer. , 2013, Human pathology.

[46]  L. Coussens,et al.  B cells and their mediators as targets for therapy in solid tumors. , 2013, Experimental cell research.

[47]  L. Holmberg,et al.  The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. , 2013, Cancer letters.

[48]  F. Balkwill,et al.  B regulatory cells in cancer. , 2013, Trends in immunology.

[49]  F. Nestle,et al.  IgG4 subclass antibodies impair antitumor immunity in melanoma , 2013 .

[50]  P. Watson,et al.  CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer , 2012, Clinical Cancer Research.

[51]  F. Nestle,et al.  Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies , 2011, PloS one.

[52]  C. Bokemeyer,et al.  Autoantibodies against tumor-related antigens: incidence and biologic significance. , 2010, Human immunology.

[53]  N. Halama,et al.  Seromic profiling of ovarian and pancreatic cancer , 2010, Proceedings of the National Academy of Sciences.

[54]  Luigi Naldini,et al.  FcRgamma activation regulates inflammation-associated squamous carcinogenesis. , 2010, Cancer cell.

[55]  L. Cavacini,et al.  Structure and function of immunoglobulins. , 2010, The Journal of allergy and clinical immunology.

[56]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[57]  T. Dønnem,et al.  Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.

[58]  R. Tisch,et al.  Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice , 2007, Proceedings of the National Academy of Sciences.

[59]  P. Parren,et al.  Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange , 2007, Science.

[60]  John D. Hunter,et al.  Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.

[61]  M. Nakamoto,et al.  Antibody-Dependent Cellular Cytotoxicity Mediated by Cetuximab against Lung Cancer Cell Lines , 2007, Clinical Cancer Research.

[62]  K. Sugio,et al.  Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer. , 2006, Anticancer research.

[63]  Y. Ron,et al.  Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. , 2001, International immunology.

[64]  N. Kohno,et al.  Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer. , 2000, American journal of respiratory and critical care medicine.

[65]  J. Nyhus,et al.  Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies. , 1999, Neoplasia.

[66]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[67]  R. Aalberse,et al.  The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds. , 2001, Molecular immunology.

[68]  F. Seiler,et al.  [Structure and function of immunoglobulins]. , 1982, Beitrage zu Infusionstherapie und klinische Ernahrung.

[69]  Elizabeth Brunk,et al.  Antigen receptor repertoire profiling from RNA-seq data , 2022 .